Ecolab (ECL) official guidance

That provides a clear path to meet or exceed our long-term adjusted EPS growth target of 12%-15% in 2027.

Adjusted EPS growth is expected to accelerate in the second half of next year as we lap M&A transaction impact and operating performance continue to accelerate.

We expect organic sales growth to grow at the upper end of our 5%-7% target and Ecolab's adjusted operating income margin to reach the 20% that we promised.

Our expectation on this business right now is because we're continuing to invest in this business, so the underlying margins are higher, more similar to what you saw in Q3, but expect Q4 margins to be in this mid to high teens level.

We expect organic sales growth to grow at the upper end of our 5%-7% target and Ecolab's adjusted operating income margin to reach the 20% that we promised.

When I think about the top line, it's also going to be, and that's assuming obviously that the inflation of DPC is kind of leveling out at some point, that the first half of the year is going to be stronger in pricing and volume is going to be still in this 1%-2%. Then the second half volume is going to be faster, so kind of 2%-3%, and pricing is going to be a bit lower because you'll be lapping against what we did in 2026 in the second half. So underlying growth, it's really to think this strong top line, 1%-2% volume, 5%-6% pricing, and then the bottom line at this mid-teens type of growth.

Then the second half volume is going to be faster, so kind of 2%-3%, and pricing is going to be a bit lower because you'll be lapping against what we did in 2026 in the second half.

When I think about the top line, it's also going to be, and that's assuming obviously that the inflation of DPC is kind of leveling out at some point, that the first half of the year is going to be stronger in pricing and volume is going to be still in this 1%-2%.

Then the second half volume is going to be faster, so kind of 2%-3%, and pricing is going to be a bit lower because you'll be lapping against what we did in 2026 in the second half.

As a result, Ecolab expects full year 2026 adjusted diluted earnings per share to be in the $8.10 to $8.20 range, rising 8% to 9% versus last year.

As a result, Ecolab expects fourth quarter 2026 adjusted diluted earnings per share in the $2.13 to $2.23 range, rising 2% to 7% compared with adjusted diluted earnings per share of $2.08 a year ago.

Life Sciences’ organic operating income margin in the fourth quarter is expected to remain on its high-teens mid-term trajectory, reflecting very strong underlying performance and continued investments in breakthrough innovation, global capabilities, and capacity to fuel this high-growth, high-margin business.

Pest Elimination's organic operating income margin over the next few quarters is expected to be in the high-teens to 20% range, reflecting growth investments to accelerate deployment of Ecolab's differentiated pest intelligence platform.

The company anticipates adjusted operating income margin in the fourth quarter to be approximately 19% and an organic operating income margin to be approximately 20%.

We expect organic sales to grow at the upper end of our 5% to 7% target and Ecolab's adjusted operating income margin to reach 20%.

Organic sales growth in the fourth quarter of 2026 is expected to remain strong in the 6% to 7% range.

Together, these acquisitions are expected to add two percentage points to Ecolab's annual organic sales growth one year after close with increasing margins.

This year, we expect Ovivo Electronics to grow mid-teens and CoolIT to more than double, compared with pre-acquisition sales.

This year, we expect Ovivo Electronics to grow mid-teens and CoolIT to more than double, compared with pre-acquisition sales.

With continued strong pricing, further volume growth, and the acquisitions of Ovivo Electronics and CoolIT, Ecolab expects reported sales in the fourth quarter of 2026 to increase 12% to 14%.